Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FXLV1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,262
Award facts
- Contract value 100% obligated
- $17,262.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,262.01 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on November 13, 2025, with completion scheduled for November 14, 2025. This delivery order was competitively awarded with firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's corporate office location also serves as the place of performance for this contract.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dupixent is a specialty pharmaceutical product used in the treatment of atopic conditions, and its procurement through this vehicle supports the Defense Health Agency and other federal healthcare systems. AmerisourceBergen Drug Corp's extensive federal contract portfolio and competitive performance across multiple therapeutic domains demonstrate its capacity to meet the specialized medical supply requirements of the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FXLV1?
SPE2DR26FXLV1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FXLV1 worth?
The government has obligated $17,262 on SPE2DR26FXLV1.
Is contract SPE2DR26FXLV1 an order under another contract?
Yes. SPE2DR26FXLV1 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXLV1 competed?
The extent of competition for SPE2DR26FXLV1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award